GMO Emerging Countries Fund

Class Other (GMCEX)
Scorecard
2 / 5 Stars
Lipper
1 2 1 4 1
Zacks Investment Research
1 (Strong Buy)
Standard & Poor's
2 / 5 Stars
TheStreet.com
E (Sell)

#60 in Diversified Emerging Mkts

U.S. News evaluated 202 Diversified Emerging Mkts Funds. Our list highlights the top-rated funds for long-term investors based on the ratings of leading fund industry researchers.

See all GMO funds

See full Diversified Emerging Mkts rankings

See more fund rankings

Performance

The fund has returned -10.61 percent over the past year, -4.96 percent over the past three years, 14.92 percent over the past five years, and 8.27 percent over the past decade.

Trailing Returns Updated 02.28.2014
Year to date -5.0%
1 Year -10.6%
3 Years (Annualized) -5.0%
5 Years (Annualized) 14.9%
10 Years (Annualized) 8.3%

See more GMCEX performance

Summary

The investment seeks total return in excess of that of its benchmark, the S&P/IFCI Composite Index. The fund typically makes equity investments directly and indirectly in companies tied economically to emerging countries. It normally invests directly and indirectly at least 80% of its assets in investments tied economically to emerging countries. The fund also may invest in U.S. Treasury Fund and money market funds that are unaffiliated with GMO. It is non-diversified.

Fees

Fees are Low compared to funds in the same category.
GMO Emerging Countries Fund has an expense ratio of 1.18 percent.

See more GMCEX fees

Risk

Risk is Above Average compared to funds in the same category according to Morningstar.

See more GMCEX risk